The paper published by these EORTC Imaging Group investigators highlights the most recent developments in MRI and PET and elucidates how these techniques can be used to detect bone metastases at an early stage as well as monitor the response of these to treatment. …
source : http://www.sciencedaily.com/releases/2014/04/140429092653.htm
source : http://www.sciencedaily.com/releases/2014/04/140422113441.htm
source : http://www.sciencedaily.com/releases/2014/01/140128113330.htm
Prof. Bernard Nordlinger of the Centre Hospitalier Universitaire Ambroise Paré, Assistance Publique-Hôpitaux de Paris, Université de Versailles, Boulogne- Billancourt, France, and member of the EORTC Gastrointestinal Tract Cancer Group says, "Surgery is currently the only potentially curative treatment for resectable liver metastases, yet only 15-20% of patients with hepatic metastases are initially eligible for a radical surgical treatment. Furthermore, less than one half of patients who do receive such treatment achieve 5-year survival after resection. This is likely due to the presence of residual disease, so it is thought that adjuvant chemotherapy could help these patients." EORTC intergroup trial 40983 recruited 364 patients between the ages of 18-80 years with colorectal cancer and up to four liver metastases. …
Dr. Andrew Bottomley, EORTC Headquarters Associate Director says, "This study utilized a single standardized and validated patient self-assessment tool, the EORTC Core Quality of Life Questionnaire, or the QLQ-C30 for short. We selected thirty EORTC randomized controlled trials which involved eleven different cancer sites for this study. …
The idea of treating cancer with a vaccine has been around since the first vaccines against infectious disease were developed. …